Paul Willner
Overview
Explore the profile of Paul Willner including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
72
Citations
1767
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Langdon P, Marczak M, Clifford C, Willner P
J Intellect Dev Disabil
. 2025 Jan;
47(3):195-205.
PMID: 39818573
Objectives: To characterise the changes at work experienced by psychologists working with people with intellectual disabilities during the pandemic and whether these changes, stressors and aspects of working life were...
2.
Langdon P, Bisson J, Rogers G, Swain S, Hiles S, Watkins A, et al.
Br J Clin Psychol
. 2023 Mar;
62(2):471-482.
PMID: 36932469
Aims: The International Trauma Questionnaire (ITQ) is a novel assessment instrument that is aligned to the ICD-11 diagnoses of post-traumatic stress disorder (PTSD) and complex PTSD (CPTSD). The purpose of...
3.
Papp M, Willner P
Curr Protoc
. 2023 Mar;
3(3):e712.
PMID: 36892313
This article describes a chronic mild stress (CMS) model for predicting antidepressant response and investigating mechanisms of antidepressant action in rats. Following exposure to a variety of mild stressors for...
4.
Papp M, Gruca P, Litwa E, Lason M, Willner P
Prog Neuropsychopharmacol Biol Psychiatry
. 2023 Jan;
123:110715.
PMID: 36610613
Background: Our earlier study demonstrated that repeated optogenetic stimulation of afferents from ventral hippocampus (vHIP) to the prelimbic region of medial prefrontal cortex (mPFC) overcame resistance to antidepressant treatment in...
5.
Rose J, Willner P, Cooper V, Langdon P, Murphy G, Stenfert Kroese B
Int J Dev Disabil
. 2022 Mar;
68(2):234-236.
PMID: 35309704
No abstract available.
6.
Papp M, Gruca P, Lason M, Litwa E, Solecki W, Willner P
Psychopharmacology (Berl)
. 2022 Mar;
239(7):2299-2307.
PMID: 35292832
Background: High frequency optogenetic stimulation (OGS) of prelimbic cortex (PLC) has been reported to exert antidepressant-like effects in the chronic mild stress model of depression in Wistar Kyoto (WKY) rats,...
7.
Vanderschuren L, Jutkiewicz E, Willner P, Ellenbroek B
Behav Pharmacol
. 2022 Mar;
33(2&3):61-62.
PMID: 35288508
No abstract available.
8.
Papp M, Gruca P, Lason M, Litwa E, Solecki W, Willner P
J Psychopharmacol
. 2021 Oct;
35(10):1253-1264.
PMID: 34617804
Background: There is extensive evidence that antidepressant drugs restore normal brain function by repairing damage to ventral hippocampus (vHPC) and medial prefrontal cortex (mPFC). While the damage is more extensive...
9.
Patel V, Perez-Olivas G, Stenfert Kroese B, Rogers G, Rose J, Murphy G, et al.
J Policy Pract Intellect Disabil
. 2021 Jul;
18(4):254-262.
PMID: 34226830
Background: The recent COVID-19 pandemic led to widespread international restrictions, severely impacting on health and social care services. For many individuals with an intellectual disability (ID) this meant reduced access...
10.
Papp M, Cubala W, Swiecicki L, Newman-Tancredi A, Willner P
Br J Pharmacol
. 2021 Jun;
179(17):4181-4200.
PMID: 34128229
A high proportion of depressed patients fail to respond to antidepressant drug treatment. Treatment-resistant depression (TRD) is a major challenge for the psychopharmacology of mood disorders. Only in the past...